Reaction
Adenoviral Hepatitis reporting signals
As of the last recalculation, Adenoviral Hepatitis appears in 229 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 260.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anti-Thymocyte Globulin (Rabbit) | 21 | 260.4 | 261.1 |
| Fludarabine Phosphate | 69 | 227.8 | 228.2 |
| Busulfan | 28 | 184.1 | 184.5 |
| Melphalan | 34 | 159.4 | 159.6 |
| Melphalan Hydrochloride | 35 | 149.6 | 149.8 |
| Posaconazole Delayed-Release | 16 | 142.3 | 142.5 |
| Micafungin Sodium | 10 | 112.1 | 112.2 |
| Posaconazole | 17 | 102.6 | 102.7 |
| Ganciclovir Sodium | 11 | 99.2 | 99.3 |
| Valganciclovir | 18 | 94.1 | 94.2 |
| Valganciclovir Hydrochloride | 18 | 94.1 | 94.2 |
| Ganciclovir | 10 | 92.8 | 92.9 |
| Vincristine Sulfate | 26 | 90.8 | 90.9 |
| Acetylcysteine | 9 | 90.3 | 90.4 |
| Azacitidine For | 14 | 74.4 | 74.5 |
| Ifosfamide | 15 | 67.8 | 67.9 |
| Sorafenib | 14 | 65.2 | 65.2 |
| Valganciclovir Hydrochloride Powder, | 8 | 61.7 | 61.8 |
| Thiotepa | 6 | 58.6 | 58.7 |
| Azacitidine | 14 | 45.6 | 45.6 |
| Gemcitabine | 15 | 37.0 | 37.0 |